Endoscopy Unit, Pulmonary Hospital, Zakopane, Poland.
Eur J Cardiothorac Surg. 2010 May;37(5):1175-9. doi: 10.1016/j.ejcts.2009.11.015. Epub 2009 Dec 22.
This prospective study aimed to assess the diagnostic yield of the combined approach - endobronchial (EBUS) and endoscopic (EUS) ultrasound-guided needle aspiration (combined ultrasound-needle aspiration (CUS-NA)) in the radiologically normal mediastinum in non-small-cell lung cancer (NSCLC) staging.
CUS-NA was performed simultaneously under local anaesthesia and sedation in consecutive NSCLC patients with mediastinal nodes that were not enlarged on CT (stage IA-IIB). All patients with negative CUS-NA subsequently underwent the transcervical extended bilateral mediastinal lymphadenectomy (TEMLA) as a confirmatory test.
A total of 120 NSCLC patients underwent CUS-NA between 1 January 2008 and 31 December 2008. There were 318 mediastinal nodes biopsied (158 EBUS-NA - stations: 2R - 2, 2L - 1, 4R - 34, 4L - 33 and 7 - 88 and 160 EUS-NA - stations: 4L - 57, 7 - 101 and 9 - 2). CUS-NA revealed metastatic lymph node involvement in 19 of 120 patients (16%) and in 31 of 318 biopsies (10%). The prevalence was 22%. In 99 patients with negative CUS-NA, who underwent subsequent TEMLA, metastatic nodes were diagnosed in nine patients (8%) in 11 stations: 2R - 2, 4R - 4, 4L - 1, 5 - 3 and 7 - 1. In all but one patient there were 'minimal N2' only. Diagnostic sensitivity, specificity, total accuracy, positive predictive value (PPV) and negative predictive value (NPV) of CUS-NA for normal mediastinum was 68% (95% confidence interval (CI): 48-84), 98% (95% CI: 92-100), 91% (95% CI: 86-96), 91% (95% CI: 70-99) and 91% (95% CI: 83-96), respectively. The sensitivity of CUS-NA was significantly higher than with EBUS-NA alone (p=0.04) and higher, close to the level of significance than with EUS-NA alone (p=0.07). The NPV of all techniques was high and that of CUS-NA was significantly higher than EBUS-NA alone and EUS-NA alone (p=0.01, p=0.03). No complications of CUS-NA were observed.
In the radiologically normal mediastinum, CUS-NA is a highly effective and safe technique in NSCLC staging and, if negative, a surgical diagnostic exploration of the mediastinum may be omitted.
本前瞻性研究旨在评估支气管内超声(EBUS)和内镜超声(EUS)引导下针吸活检(联合超声针吸(CUS-NA))在非小细胞肺癌(NSCLC)分期中对影像学正常纵隔的诊断效果。
对纵隔淋巴结 CT 未肿大(IA-IIB 期)的连续 NSCLC 患者,在局部麻醉和镇静下同时进行 CUS-NA。所有 CUS-NA 阴性的患者随后接受经颈扩大双侧纵隔淋巴结清扫术(TEMLA)作为确证性检查。
2008 年 1 月 1 日至 2008 年 12 月 31 日期间,共有 120 例 NSCLC 患者接受了 CUS-NA 检查。共活检了 318 个纵隔淋巴结(158 个 EBUS-NA 站:2R-2、2L-1、4R-34、4L-33 和 7-88,160 个 EUS-NA 站:4L-57、7-101 和 9-2)。CUS-NA 在 120 例患者中的 19 例(16%)和 318 个活检标本中的 31 例(10%)中发现了转移性淋巴结受累。患病率为 22%。在 99 例 CUS-NA 阴性的患者中,有 9 例(8%)在 11 个站(2R-2、4R-4、4L-1、5-3 和 7-1)诊断出转移性淋巴结。除 1 例患者外,其余均为“微转移 N2”。CUS-NA 对正常纵隔的诊断灵敏度、特异性、总准确率、阳性预测值(PPV)和阴性预测值(NPV)分别为 68%(95%CI:48-84)、98%(95%CI:92-100)、91%(95%CI:86-96)、91%(95%CI:70-99)和 91%(95%CI:83-96)。CUS-NA 的灵敏度明显高于 EBUS-NA 单独检查(p=0.04),且与 EUS-NA 单独检查接近统计学意义(p=0.07)。所有技术的 NPV 均较高,CUS-NA 的 NPV 明显高于 EBUS-NA 单独检查和 EUS-NA 单独检查(p=0.01,p=0.03)。CUS-NA 无并发症发生。
在影像学正常的纵隔中,CUS-NA 是一种非常有效的安全技术,如果为阴性,则可省略纵隔的外科诊断性探查。